Application of LncRNA-TUG1 in preparation of drug for regulating and controlling dryness maintenance capacity of periodontal ligament stem cells
A technology of periodontal ligament stem cells and ability, applied in the application field of medicine, can solve the problems of reporting the stemness maintenance ability of periodontal ligament stem cells, and achieve the effect of precision medicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1: Research on the biological characteristics of periodontal ligament stem cells
[0036] 1. Isolation and culture of human periodontal ligament stem cells
[0037] Under anesthesia, the human impacted third molar was aseptically extracted, and the periodontal tissue around it was gently peeled off. The periodontal tissue in the middle was taken, washed repeatedly with PBS, cut into small pieces, and placed in a solution containing type Ⅰ collagenase (3g / L) and Dispase II enzyme (4g / L) digestion solution, digested at 37°C for 40 minutes, collected cells through a 70um cell sieve, centrifuged at 1000 rpm for 5 minutes, removed the upper liquid, and resuspended into a single cell suspension with fresh culture medium liquid. Cells were seeded at 25cm 2 In a cell culture flask, in α-MEM medium (containing 15% fetal bovine serum, 2 mmol / L glutamine, 100 U / ml penicillin and 100 μg / ml streptomycin) at 37 °C, 5% CO 2 For culture, the medium was changed every 2-3 days...
Embodiment 2
[0046] Example 2: Regulatory effect of LncRNA-TUG1 on the stemness maintenance ability of periodontal ligament stem cells
[0047] 1. Construction of lentiviral vector:
[0048] Primers were designed according to the human LncRNA-TUG1 sequence (ID: 55000), and the primers were synthesized and purified by Shanghai Lingke Biotechnology Co., Ltd. After annealing, it was ligated to the linearized pGenesil-1 plasmid to construct the lncRNA-TUG1 (silencing) expression vector lentivirus to inhibit the expression of LncRNA-TUG1.
[0049] details as follows:
[0050] Vector: pLenO-GFP
[0051] Lenti-human-NC sequence: TTCTCCGAACGTGTCACGT (SEQ ID NO: 1); (NegativeControl).
[0052] Lenti-human-sh1 TUG1
[0053] GPH-hTUG1-SH1 Forward Sequence
[0054] 5'-GATCCCTGTTGACCTTGCTGTGAGAACTTCCTGTCAGATTCTCACAGCAAGGTCCAACAGTTTTTG-3' (SEQ ID NO: 2);
[0055] GPH-hTUG1-SH1 Reverse Sequence
[0056] 5'-AATTCAAAAACTGTTGACCTTGCTGTGAGAATCTGACAGGAAGTTTCCACAAGGTCAACAGG-3' (SEQ ID NO: 3).
[0057] ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com